138 related articles for article (PubMed ID: 9021916)
21. IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4+ T cell-mediated protective immunity against herpes simplex virus-2 challenge.
Sin JI; Kim JJ; Arnold RL; Shroff KE; McCallus D; Pachuk C; McElhiney SP; Wolf MW; Pompa-de Bruin SJ; Higgins TJ; Ciccarelli RB; Weiner DB
J Immunol; 1999 Mar; 162(5):2912-21. PubMed ID: 10072541
[TBL] [Abstract][Full Text] [Related]
22. Enhancement of protective humoral (Th2) and cell-mediated (Th1) immune responses against herpes simplex virus-2 through co-delivery of granulocyte-macrophage colony-stimulating factor expression cassettes.
Sin JI; Kim JJ; Ugen KE; Ciccarelli RB; Higgins TJ; Weiner DB
Eur J Immunol; 1998 Nov; 28(11):3530-40. PubMed ID: 9842896
[TBL] [Abstract][Full Text] [Related]
23. Dendritic cells from mice neonatally vaccinated with modified vaccinia virus Ankara transfer resistance against herpes simplex virus type I to naive one-week-old mice.
Franchini M; Hefti H; Vollstedt S; Glanzmann B; Riesen M; Ackermann M; Chaplin P; Shortman K; Suter M
J Immunol; 2004 May; 172(10):6304-12. PubMed ID: 15128820
[TBL] [Abstract][Full Text] [Related]
24. Antibody-inducing properties of a prototype bivalent herpes simplex virus/enterotoxigenic Escherichia coli DNA vaccine.
Lásaro MO; Alves AM; Botosso VF; Durigon EL; Ferreira LC
FEMS Immunol Med Microbiol; 2003 Jan; 35(1):25-31. PubMed ID: 12589954
[TBL] [Abstract][Full Text] [Related]
25. Immune-enhancing effect of nano-DNA vaccine encoding a gene of the prME protein of Japanese encephalitis virus and BALB/c mouse granulocyte-macrophage colony-stimulating factor.
Zhai Y; Zhou Y; Li X; Feng G
Mol Med Rep; 2015 Jul; 12(1):199-209. PubMed ID: 25738258
[TBL] [Abstract][Full Text] [Related]
26. Immunogenicity and protective effect of a DNA construct encoding certain neutralizing epitopes of herpes simplex virus type-1 glycoprotein B.
Bamdad T; Roostaee MH; Sadeghizadeh M; Mahboudi F; Kazemnejad A; Soleimanjahi H
Folia Biol (Praha); 2005; 51(4):109-13. PubMed ID: 16180546
[TBL] [Abstract][Full Text] [Related]
27. Identification of novel immunodominant CD4+ Th1-type T-cell peptide epitopes from herpes simplex virus glycoprotein D that confer protective immunity.
BenMohamed L; Bertrand G; McNamara CD; Gras-Masse H; Hammer J; Wechsler SL; Nesburn AB
J Virol; 2003 Sep; 77(17):9463-73. PubMed ID: 12915561
[TBL] [Abstract][Full Text] [Related]
28. Plasmid DNA vaccines are effective in the absence of IFNgamma.
Hassett DE; Zhang J; Whitton JL
Virology; 1999 Oct; 263(1):175-83. PubMed ID: 10544092
[TBL] [Abstract][Full Text] [Related]
29. Plasmid DNA-expressed secreted and nonsecreted forms of herpes simplex virus glycoprotein D2 induce different types of immune responses.
Higgins TJ; Herold KM; Arnold RL; McElhiney SP; Shroff KE; Pachuk CJ
J Infect Dis; 2000 Nov; 182(5):1311-20. PubMed ID: 11023455
[TBL] [Abstract][Full Text] [Related]
30. A novel adjuvant, the general opioid antagonist naloxone, elicits a robust cellular immune response for a DNA vaccine.
Jamali A; Mahdavi M; Hassan ZM; Sabahi F; Farsani MJ; Bamdad T; Soleimanjahi H; Motazakker M; Shahabi S
Int Immunol; 2009 Mar; 21(3):217-25. PubMed ID: 19174474
[TBL] [Abstract][Full Text] [Related]
31. Ectopic expression of DNA encoding IFN-alpha 1 in the cornea protects mice from herpes simplex virus type 1-induced encephalitis.
Noisakran S; Campbell IL; Carr DJ
J Immunol; 1999 Apr; 162(7):4184-90. PubMed ID: 10201945
[TBL] [Abstract][Full Text] [Related]
32. DNA vaccines encoding interleukin-8 and RANTES enhance antigen-specific Th1-type CD4(+) T-cell-mediated protective immunity against herpes simplex virus type 2 in vivo.
Sin J; Kim JJ; Pachuk C; Satishchandran C; Weiner DB
J Virol; 2000 Dec; 74(23):11173-80. PubMed ID: 11070014
[TBL] [Abstract][Full Text] [Related]
33. [Comparison of adjuvant activities of glucosaminyl-muramyl dipeptide and of the gene coding for granulocyte-macrophage colony-stimulating factor in DNA immunization against herpes simplex virus].
Kozlov AIu; Klimova RR; Shingarova LN; Boldyreva EF; Nekrasova OV; Gur'ianova SV; Andronova TM; Novikov VV; Kushch AA
Mol Biol (Mosk); 2005; 39(3):504-12. PubMed ID: 15981580
[TBL] [Abstract][Full Text] [Related]
34. Enhancement of antigen acquisition by dendritic cells and MHC class II-restricted epitope presentation to CD4+ T cells using VP22 DNA vaccine vectors that promote intercellular spreading following initial transfection.
Mwangi W; Brown WC; Splitter GA; Zhuang Y; Kegerreis K; Palmer GH
J Leukoc Biol; 2005 Aug; 78(2):401-11. PubMed ID: 15857936
[TBL] [Abstract][Full Text] [Related]
35. Prime-boost immunization with DNA and modified vaccinia virus ankara vectors expressing herpes simplex virus-2 glycoprotein D elicits greater specific antibody and cytokine responses than DNA vaccine alone.
Meseda CA; Elkins KL; Merchlinsky MJ; Weir JP
J Infect Dis; 2002 Oct; 186(8):1065-73. PubMed ID: 12355355
[TBL] [Abstract][Full Text] [Related]
36. Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes.
Manickan E; Rouse RJ; Yu Z; Wire WS; Rouse BT
J Immunol; 1995 Jul; 155(1):259-65. PubMed ID: 7602102
[TBL] [Abstract][Full Text] [Related]
37. Prophylactic herpes simplex virus type 2 vaccine adjuvanted with a universal CD4 T cell helper peptide induces long-term protective immunity against lethal challenge in mice.
Li X; Zhang S; Lei J; Zhu Y; Zhou X; Xiao J; Xiang T
Int Immunopharmacol; 2018 Aug; 61():100-108. PubMed ID: 29857239
[TBL] [Abstract][Full Text] [Related]
38. DNA is an efficient booster of dendritic cell-based vaccine.
Li J; Valentin A; Beach RK; Alicea C; Felber BK; Pavlakis GN
Hum Vaccin Immunother; 2015; 11(8):1927-35. PubMed ID: 26125100
[TBL] [Abstract][Full Text] [Related]
39. Plasmid DNA encoding influenza virus haemagglutinin induces Th1 cells and protection against respiratory infection despite its limited ability to generate antibody responses.
Johnson PA; Conway MA; Daly J; Nicolson C; Robertson J; Mills KH
J Gen Virol; 2000 Jul; 81(Pt 7):1737-45. PubMed ID: 10859379
[TBL] [Abstract][Full Text] [Related]
40. Human dendritic cells transduced with herpes simplex virus amplicons encoding human immunodeficiency virus type 1 (HIV-1) gp120 elicit adaptive immune responses from human cells engrafted into NOD/SCID mice and confer partial protection against HIV-1 challenge.
Gorantla S; Santos K; Meyer V; Dewhurst S; Bowers WJ; Federoff HJ; Gendelman HE; Poluektova L
J Virol; 2005 Feb; 79(4):2124-32. PubMed ID: 15681415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
